跳至主要内容
临床试验/NL-OMON48907
NL-OMON48907招募中2 期

An explorative study for halting inflammation in patients with emphysema by administration of allogeneic bone marrow derived mesenchymal stromal cells. - HEP study

ongziekten0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.Signed informed consent consistent with ICH-GCP guidelines and local
  • legislation prior to participation in the trial.
  • 2.Males or females between 45 and 65 years of age;
  • 3.Emphysema as reported by a radiologist present in CT images of the lung;
  • gradient of emphysema severity towards the lung apex as assessed by CT-derived
  • lung densitometry by Pulmo CMS software (Medis, NL) and equally distributed
  • between left and right lung.
  • 4. Pre bronchodilator value measured FEV1 between 20% and 45% predicted; TLCO
  • between 30% and 45% pred.; RV/TLC > 0.5.
  • 5. Patients in a stable clinical condition.

排除标准

  • 1. Significant cardiac failure;
  • 2. active smoking, or < 6 months smoking cessation;
  • 3. or failure to complete pulmonary rehab program before randomization;
  • 4. women of child bearing potential;
  • 5. any cancer treated in the previous 5 years;
  • 6. women of child-bearing potential not using adequate contraception;
  • 7. any other condition of the patient that the clinical investigator deemed
  • harmful for study participation.

研究者

发起方
ongziekten

相似试验